How to mend a broken heart: Advances in parthenogenic stem cells

February 22, 2013

Parthenogenesis is a form of asexual reproduction during which unfertilized eggs begin to develop as if they had been fertilized. It occurs naturally in many plants and a few invertebrate (some bees, scorpions, parasitic wasps) and vertebrate animals (some fish, reptiles, and amphibians), but does not occur naturally in mammals.

In 2007, researchers were able to chemically induce human to undergo parthenogenesis. The resulting parthenogenote has properties similar to an embryo, but cannot develop further.

In this issue of the , Wolfram Zimmerman and colleagues at Georg-August-Universität Göttingen in Göttingen, Germany, demonstrated that cells from the parthenogenote function as and maintain the capacity to develop into different types of tissue.

Further, they used parthenogenic stem cells to make cardiomyocytes and engineered heart muscle (myocardium) that exhibited the structural and functional properties of normal myocardium. The engineered myocardium could then be used to engraft the mice that had contributed the eggs for parthenogenesis.

These studies demonstrate that parthenogenic stem cells can be used for tissue engineering.

In a companion commentary, Michael Schneider of the Imperial College of London discusses how these findings could impact the development of cell replacement therapies.

Explore further: Genetically engineered cardiac stem cells repaired damaged mouse heart

More information: Parthenogenetic stem cells for tissue engineered heart repair, Journal of Clinical Investigation, 2013. doi:10.1172/JCI66854
Virgin birth: engineered heart muscle from parthenogenic stem cells, Journal of Clinical Investigation, 2013. doi:10.1172/JCI67961

Related Stories

Extracting stem cells from fat for tissue regeneration

May 3, 2011

Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered ...

Researchers grow pituitary glands from embryonic stem cells

November 10, 2011

(Medical Xpress) -- A new study published in Nature reports that scientists have been able to grow working pituitary glands from embryonic stem cells from mice. When these were transplanted into mice with defects in the pituitary ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.